Premas’ D-Crypt

Premas Biotech and Oramed Announce Oral COVID-19 Vaccine Candidate That Produces Antibodies After a Single Dose

Far reaching implications for ease of widescale distribution and administration anytime, anywhere Better candidate for protection against COVID-19 variants due…

Read More »